Lead Product(s): Solifenacin Succinate
Therapeutic Area: Urology Product Name: Undisclosed
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 27, 2020
VESIcare LS is an oral suspension dosage form that was specifically developed to facilitate dosing and administration in the pediatric population.